133 related articles for article (PubMed ID: 9001434)
1. Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia.
Bseiso AW; Kantarjian H; Estey E
Leukemia; 1997 Jan; 11(1):168-9. PubMed ID: 9001434
[TBL] [Abstract][Full Text] [Related]
2. Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
Tang YL; Chia WK; Yap EC; Julia MI; Leong CF; Salwati S; Wong CL
Malays J Pathol; 2016 Dec; 38(3):315-319. PubMed ID: 28028303
[TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia and acute pancreatitis in a male patient with acute promyelocytic leukemia and pulmonary tuberculosis.
Abdullah AS; Adel AM; Hussein RM; Abdullah MA; Yousaf A; Mudawi D; Mohamed SF; Nashwan AJ; Soliman D; Ibrahim F; Yassin MA
Acta Biomed; 2018 Apr; 89(3-S):23-27. PubMed ID: 29633729
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia.
Cortes JE; Kantarjian H; O'Brien S; Robertson LE; Koller C; Hirsh-Ginsberg C; Stass S; Keating M; Estey E
Cancer; 1994 Jun; 73(12):2946-52. PubMed ID: 8199992
[TBL] [Abstract][Full Text] [Related]
6. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up.
Avvisati G; Petti MC; Lo-Coco F; Vegna ML; Amadori S; Baccarani M; Cantore N; Di Bona E; Ferrara F; Fioritoni G; Gallo E; Invernizzi R; Lazzarino M; Liso V; Mariani G; Ricciuti F; Selleri C; Sica S; Veneri D; Mandelli F;
Blood; 2002 Nov; 100(9):3141-6. PubMed ID: 12384411
[TBL] [Abstract][Full Text] [Related]
7. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
Estey E; Thall PF; Pierce S; Kantarjian H; Keating M
J Clin Oncol; 1997 Feb; 15(2):483-90. PubMed ID: 9053469
[TBL] [Abstract][Full Text] [Related]
8. Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia.
Mathew S; Lorsbach RB; Shearer P; Sandlund JT; Raimondi SC
Leukemia; 2000 Jul; 14(7):1314-5. PubMed ID: 10914558
[No Abstract] [Full Text] [Related]
9. Acute promyelocytic leukemia: a case-based review.
Gupta V; Tabak D; Keating A
Hematology; 2003 Apr; 8(2):105-13. PubMed ID: 12745660
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
[No Abstract] [Full Text] [Related]
11. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
Snijder S; Mellink CH; van der Lelie H
Cancer Genet Cytogenet; 2008 Jan; 180(2):149-52. PubMed ID: 18206542
[TBL] [Abstract][Full Text] [Related]
12. Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
Mandelli F; Latagliata R; Avvisati G; Fazi P; Rodeghiero F; Leoni F; Gobbi M; Nobile F; Gallo E; Fanin R; Amadori S; Vignetti M; Fioritoni G; Ferrara F; Peta A; Giustolisi R; Broccia G; Petti MC; Lo-Coco F;
Leukemia; 2003 Jun; 17(6):1085-90. PubMed ID: 12764372
[TBL] [Abstract][Full Text] [Related]
13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
14. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
15. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia.
Teng HW; Bai LY; Chao TC; Wang WS; Chen PM
Jpn J Clin Oncol; 2005 Feb; 35(2):94-6. PubMed ID: 15709095
[TBL] [Abstract][Full Text] [Related]
16. High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.
Aljurf M; Al Qurashi F; Al Mohareb F; Sahovic E; Al Sharif F; Al Zahrani H; Al Shanqeeti A; Owaidah T; Iqbal A; Zaidi SZ; Nurgat ZA; Sanz M; Chaudhri N
Med Oncol; 2010 Sep; 27(3):702-7. PubMed ID: 19669610
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
18. First reported case of aplastic anemia occurring in a patient after acute promyelocytic leukemia in remission.
Pham A; Bahadini B; Alsabeh R; Steinberg A
Clin Adv Hematol Oncol; 2009 Oct; 7(10):670-4. PubMed ID: 20040907
[No Abstract] [Full Text] [Related]
19. Severe myopericarditis following induction therapy with idarubicin and transretinoic acid in a patient with acute promyelocytic leukemia.
Carcelero San Martín E; Riu Viladoms G; Creus Baró N
Med Clin (Barc); 2018 Jun; 150(12):492-493. PubMed ID: 29196036
[No Abstract] [Full Text] [Related]
20. Therapy-related acute myelomonocytic leukemia following successful treatment for acute promyelocytic leukemia.
Todisco E; Testi AM; Avvisati G; Moleti ML; Cedrone M; Cimino G; Mancini F; Amadori S; Mandelli F
Leukemia; 1995 Sep; 9(9):1583-5. PubMed ID: 7658728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
